Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Sep 26;29(19):4576.
doi: 10.3390/molecules29194576.

A Descriptive Review of the Antioxidant Effects and Mechanisms of Action of Berberine and Silymarin

Affiliations
Review

A Descriptive Review of the Antioxidant Effects and Mechanisms of Action of Berberine and Silymarin

Ana María García-Muñoz et al. Molecules. .

Abstract

Oxidative stress is a key factor in the development of chronic diseases such as type 2 diabetes, cardiovascular diseases, and liver disorders. Antioxidant therapies that target oxidative damage show significant promise in preventing and treating these conditions. Berberine, an alkaloid derived from various plants in the Berberidaceae family, enhances cellular defenses against oxidative stress through several mechanisms. It activates the AMP-activated protein kinase (AMPK) pathway, which reduces mitochondrial reactive oxygen species (ROS) production and improves energy metabolism. Furthermore, it boosts the activity of key antioxidant enzymes like superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx), thus protecting cells from oxidative damage. These actions make berberine effective in managing diseases like type 2 diabetes, cardiovascular conditions, and neurodegenerative disorders. Silymarin, a flavonolignan complex derived from Silybum marianum, is particularly effective for liver protection. It activates the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway, enhancing antioxidant enzyme expression and stabilizing mitochondrial membranes. Additionally, silymarin reduces the formation of ROS by chelating metal ions, and it also diminishes inflammation. This makes it beneficial for conditions like non-alcoholic fatty liver disease (NAFLD) and alcohol-related liver disorders. This review aims to highlight the distinct mechanisms by which berberine and silymarin exert their antioxidant effects.

Keywords: Silybum marianum; antioxidant activity; berberine; bioactive compounds; silymarin.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Mechanisms of Antioxidant Action of Berberine and Silymarin.
Figure 2
Figure 2
Systemic health effects of berberine and silymarin.

References

    1. Sharifi-Rad M., Anil Kumar N.V., Zucca P., Varoni E.M., Dini L., Panzarini E., Rajkovic J., Tsouh Fokou P.V., Azzini E., Peluso I., et al. Lifestyle, Oxidative Stress, and Antioxidants: Back and Forth in the Pathophysiology of Chronic Diseases. Front. Physiol. 2020;11:694. doi: 10.3389/fphys.2020.00694. - DOI - PMC - PubMed
    1. Huang Z.-J., Zeng Y., Lan P., Sun P.-H., Chen W.-M. Advances in Structural Modifications and Biological Activities of Berberine: An Active Compound in Traditional Chinese Medicine. Mini. Rev. Med. Chem. 2011;11:1122–1129. doi: 10.2174/138955711797655362. - DOI - PubMed
    1. Kumar A., Ekavali, Chopra K., Mukherjee M., Pottabathini R., Dhull D.K. Current Knowledge and Pharmacological Profile of Berberine: An Update. Eur. J. Pharmacol. 2015;761:288–297. doi: 10.1016/j.ejphar.2015.05.068. - DOI - PubMed
    1. Shakeri F., Kiani S., Rahimi G., Boskabady M.H. Anti-Inflammatory, Antioxidant, and Immunomodulatory Effects of Berberis Vulgaris and Its Constituent Berberine, Experimental and Clinical, a Review. Phytother. Res. 2024;38:1882–1902. doi: 10.1002/ptr.8077. - DOI - PubMed
    1. Dubey V., Kansagra J., Sureja V., Kheni D. Efficacy Evaluation of Berberis Aristata and Silybum Marianum Fixed Dose Combination on Glycaemic and Insulin Resistance Parameters in Adult Population: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Future J. Pharm. Sci. 2024;10:28. doi: 10.1186/s43094-024-00603-7. - DOI

LinkOut - more resources